ResearcherNational and Kapodistrian University of AthensActive in the last 2 years
Konstantinos G. Toutouzas
Matched on ORCID iD 0000-0002-7830-6945; OpenAlex author ID A5084036141. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 0, last author 4)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 7
2022: 1 paper · 2023: 1 paper · 2024: 1 paper · 2025: 2 papers
Papers 5
- Emerging Tumor Biomarkers in Pancreatic Cancer and Their Clinical Implications. Last author DOI 10.3390/cimb47050347↗
- Exploring the Link Between Nutritional and Functional Status and Short-Term Postoperative Outcomes in Patients Undergoing Pancreatic Cancer Surgery. Co-author DOI 10.3390/life15050803↗
- Significance of TP53, CDKN2A, SMAD4 and KRAS in Pancreatic Cancer. Last author DOI 10.3390/cimb46040177↗
- "Oligometastatic pancreatic cancer" definition: The first step. Last author DOI 10.1016/j.hbpd.2022.07.002↗
- The impact of surgery delay on survival of resectable pancreatic cancer: A systematic review of observational studies. Last author DOI 10.1016/j.suronc.2022.101855↗
Closest collaborators
The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Maximos Frountzas · 5 shared papers, 2022–2025 · strength 1.22
- Paper Emerging Tumor Biomarkers in Pancreatic Cancer and Their Clinical Implications. DOI 10.3390/cimb47050347↗
- Paper "Oligometastatic pancreatic cancer" definition: The first step. DOI 10.1016/j.hbpd.2022.07.002↗
- Paper Significance of TP53, CDKN2A, SMAD4 and KRAS in Pancreatic Cancer. DOI 10.3390/cimb46040177↗
- Dimitriοs Schizas · 5 shared papers, 2022–2025 · strength 1.22
- Paper Emerging Tumor Biomarkers in Pancreatic Cancer and Their Clinical Implications. DOI 10.3390/cimb47050347↗
- Paper "Oligometastatic pancreatic cancer" definition: The first step. DOI 10.1016/j.hbpd.2022.07.002↗
- Paper Significance of TP53, CDKN2A, SMAD4 and KRAS in Pancreatic Cancer. DOI 10.3390/cimb46040177↗
- Dimitrios Stefanoudakis · 3 shared papers, 2024–2025 · strength 0.78
- Paper Emerging Tumor Biomarkers in Pancreatic Cancer and Their Clinical Implications. DOI 10.3390/cimb47050347↗
- Paper Significance of TP53, CDKN2A, SMAD4 and KRAS in Pancreatic Cancer. DOI 10.3390/cimb46040177↗
- Paper Exploring the Link Between Nutritional and Functional Status and Short-Term Postoperative Outcomes in Patients Undergoi… DOI 10.3390/life15050803↗
- Michail G. Vailas · 2 shared papers, 2022–2025 · strength 0.39
- Paper Exploring the Link Between Nutritional and Functional Status and Short-Term Postoperative Outcomes in Patients Undergoi… DOI 10.3390/life15050803↗
- Paper The impact of surgery delay on survival of resectable pancreatic cancer: A systematic review of observational studies. DOI 10.1016/j.suronc.2022.101855↗
- Alexandra Drakaki · 1 shared paper, 2024 · strength 0.26
- Evangelos S. Felekouras · 1 shared paper, 2025 · strength 0.22
- Irene Lidoriki · 1 shared paper, 2025 · strength 0.22
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.